Reaction
Orchitis reporting signals
As of the last recalculation, Orchitis appears in 1,049 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 27.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 16 | 27.4 | 27.4 |
| Valganciclovir Hydrochloride Powder, | 14 | 23.1 | 23.1 |
| Dapagliflozin | 35 | 22.8 | 22.8 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 22.3 | 22.3 |
| Valganciclovir | 18 | 19.3 | 19.3 |
| Valganciclovir Hydrochloride | 18 | 19.3 | 19.3 |
| Empagliflozin | 43 | 13.2 | 13.2 |
| Sevelamer Carbonate | 4 | 6.9 | 6.9 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 3 | 6.7 | 6.7 |
| Ixekizumab | 8 | 4.3 | 4.3 |